Multiple System Atrophy - 30 Studies Found

Completed : PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)
:
  • Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
  • : 2014-01-10
Completed : Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach
: Multiple System Atrophy
: 2013-12-08
:
  • Drug: EGCG as putative neuroprotective agent

Completed : Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.
:
  • Parkinson Disease
  • Multiple System Atrophy

: 2014-02-13
: Drug: Intranasal Insulin
  • t
    		•
    Completed : AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
    : Multiple System Atrophy (MSA)
    : 2015-03-09
    :
    • Drug: AZD3241 Drug: AZD3241 ad
    Completed : Assessment of Ambulatory Polygraphy in the Detection of Sleep Apnea in Multiple System Atrophy (SAMSA)
    :
    • Sleep Apnea Syndromes
    • Multiple System Atrophy

    : 2008-08-28
    :
    • Device: Polysomnography Simult
    Completed : Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA
    : Multiple System Atrophy
    : 2014-02-21
    :
    • Drug: L-Threo DOPS initial dos
    Completed : Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study
    : Multisystemic Atrophy
    : 2010-01-06
    :
    • Radiation: H215O PET H215O PET
    Completed : Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy
    :
    • Parkinson's Disease
    • Multiple System Atrophy
    • Drug: Fludrocortisone
    • Drug: Domperidone
    Terminated : Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)
    :
    • Multiple System Atrophy
    • Progressive Supranuclear Palsy
      • : 2005-09-13
      : Drug: Riluzole
    Active, not recruiting : Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA
    :
    • Multiple System Atrophy
    • Neurodegenerative Diseases

    : 2014-09-04
    :
    • Biological: AFFITOPE® PD01A + Adjuvant

    <<< Previous | Next >>>